Impact of MyD88 Deficiency on Innate Immune Function in COVID-19 Infection and Allotransplantation
- 25 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 107 (10) , 2084-2086
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunityImmunologic Research, 2021
- Effects of Antirejection Drugs on Innate Immune Cells After Kidney TransplantationFrontiers in Immunology, 2019
- Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft RejectionJournal of the American Society of Nephrology, 2015
- IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensBlood, 2014
- MyD88: a central player in innate immune signalingF1000Prime Reports, 2014
- A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4Nature Immunology, 2014
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Monocyte Differentiation Is Controlled by MyD88 After Mouse Orthotopic Lung TransplantationTransplantation Proceedings, 2009
- Pyogenic Bacterial Infections in Humans with MyD88 DeficiencyScience, 2008
- Absence of Innate MyD88 Signaling Promotes Inducible Allograft AcceptanceThe Journal of Immunology, 2006